Eva Barragán
Department of Medical Pathology
Hospital Universitario La Fe Valencia
Spain
Name/email consistency: high
- Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression. Barragan, E., Pajuelo, J.C., Ballester, S., Fuster, O., Cervera, J., Moscardo, F., Senent, L., Such, E., Sanz, M.A., Bolufer, P. Clin. Chim. Acta (2008)
- The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia. Barragan, E., Collado, M., Cervera, J., Martin, G., Bolufer, P., Roman, J., Sanz, M.A. Leuk. Res. (2007)
- Molecular detection of Spanish deltabeta-thalassemia associated with beta-thalassemia identified during prenatal diagnosis. Barragan, E., Bolufer, P., Perez, M.L., Prieto, F., Sanz, M.A. Clin. Chim. Acta (2006)
- Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Barragán, E., Cervera, J., Bolufer, P., Ballester, S., Martín, G., Fernández, P., Collado, R., Sayas, M.J., Sanz, M.A. Haematologica (2004)